2019-LB: The Characteristic Activity of Regulatory B Cells during the Occurrence and Development of Insulin Resistance
Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of individuals with different levels of insulin resistance (IR). Methods: A cohort of 124 subjects were divided into five groups according to th...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 73; no. Supplement_1; p. 1 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
American Diabetes Association
14.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of individuals with different levels of insulin resistance (IR).
Methods: A cohort of 124 subjects were divided into five groups according to their insulin resistance index (HOMA-IR) and diabetes diagnosis. The groups comprised HOMA-IR<3 (IR- without T2DM), HOMA-IR<3 (IR- with T2DM), 3≤HOMA-IR<6 (IR+ without T2DM), 3≤HOMA-IR < 6 (IR+ without T2DM) and HOMA-IR≥6 (IR++ with T2DM). Peripheral blood samples were collected from each group, the percentages of CD19+CD24+CD27+ and CD19+CD24+CD38+ Bregs and the levels of IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α, IFN-γ were detected by flow cytometry and flow microsphere matrix method. Additionally, the cytokines levels were validated through ELISA. The activation of Bregs and the production of IL-10 among different groups were analyzed. Spearman correlation analysis was used to analyze the correlation between Bregs activation rate and IR degree.
Results: The results showed that the levels of CD19+CD24+CD27+ and CD19+CD24+CD38+ cells were increased whether in IR+ without or with T2DM groups compared to the IR- group, with the most significant increase observed in the IR++ with T2DM group. Moreover, the plasma levels of IL-6, IL-10, IL-17, TNF-α and IFN-γ in the IR+ group were higher than those in the IR- group. The expression and activation level of Bregs were positively correlated with the severity of IR in T2DM.
Conclusion: These results suggest that the increase level of Bregs is closely related to the severity of IR, highlighting the potential significance of Bregs in the clinical progression of Type 2 Diabetes Mellitus (T2DM) and its associated insulin resistance. |
---|---|
AbstractList | Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of individuals with different levels of insulin resistance (IR).
Methods: A cohort of 124 subjects were divided into five groups according to their insulin resistance index (HOMA-IR) and diabetes diagnosis. The groups comprised HOMA-IR<3 (IR- without T2DM), HOMA-IR<3 (IR- with T2DM), 3≤HOMA-IR<6 (IR+ without T2DM), 3≤HOMA-IR < 6 (IR+ without T2DM) and HOMA-IR≥6 (IR++ with T2DM). Peripheral blood samples were collected from each group, the percentages of CD19+CD24+CD27+ and CD19+CD24+CD38+ Bregs and the levels of IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α, IFN-γ were detected by flow cytometry and flow microsphere matrix method. Additionally, the cytokines levels were validated through ELISA. The activation of Bregs and the production of IL-10 among different groups were analyzed. Spearman correlation analysis was used to analyze the correlation between Bregs activation rate and IR degree.
Results: The results showed that the levels of CD19+CD24+CD27+ and CD19+CD24+CD38+ cells were increased whether in IR+ without or with T2DM groups compared to the IR- group, with the most significant increase observed in the IR++ with T2DM group. Moreover, the plasma levels of IL-6, IL-10, IL-17, TNF-α and IFN-γ in the IR+ group were higher than those in the IR- group. The expression and activation level of Bregs were positively correlated with the severity of IR in T2DM.
Conclusion: These results suggest that the increase level of Bregs is closely related to the severity of IR, highlighting the potential significance of Bregs in the clinical progression of Type 2 Diabetes Mellitus (T2DM) and its associated insulin resistance. Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of individuals with different levels of insulin resistance (IR). Methods: A cohort of 124 subjects were divided into five groups according to their insulin resistance index (HOMA-IR) and diabetes diagnosis. The groups comprised HOMA-IR<3 (IR- without T2DM), HOMA-IR<3 (IR- with T2DM), 3≤HOMA-IR<6 (IR+ without T2DM), 3≤HOMA-IR < 6 (IR+ without T2DM) and HOMA-IR≥6 (IR++ with T2DM). Peripheral blood samples were collected from each group, the percentages of CD19+CD24+CD27+ and CD19+CD24+CD38+ Bregs and the levels of IL-2, IL-4, IL-6, IL-10, IL-17, TNF-α, IFN-γ were detected by flow cytometry and flow microsphere matrix method. Additionally, the cytokines levels were validated through ELISA. The activation of Bregs and the production of IL-10 among different groups were analyzed. Spearman correlation analysis was used to analyze the correlation between Bregs activation rate and IR degree. Results: The results showed that the levels of CD19+CD24+CD27+ and CD19+CD24+CD38+ cells were increased whether in IR+ without or with T2DM groups compared to the IR- group, with the most significant increase observed in the IR++ with T2DM group. Moreover, the plasma levels of IL-6, IL-10, IL-17, TNF-α and IFN-γ in the IR+ group were higher than those in the IR- group. The expression and activation level of Bregs were positively correlated with the severity of IR in T2DM. Conclusion: These results suggest that the increase level of Bregs is closely related to the severity of IR, highlighting the potential significance of Bregs in the clinical progression of Type 2 Diabetes Mellitus (T2DM) and its associated insulin resistance. |
Author | WEI, LINGLING MA, YAN ZHAO, DONG ZHANG, LIJIE YANG, LONGYAN |
Author_xml | – sequence: 1 givenname: LINGLING surname: WEI fullname: WEI, LINGLING – sequence: 2 givenname: LIJIE surname: ZHANG fullname: ZHANG, LIJIE – sequence: 3 givenname: YAN surname: MA fullname: MA, YAN – sequence: 4 givenname: DONG surname: ZHAO fullname: ZHAO, DONG – sequence: 5 givenname: LONGYAN surname: YANG fullname: YANG, LONGYAN |
BookMark | eNotkMtqwzAQRUVJoUnaXT9A0G3djiQ_ou6S9BUwBEoW3QlZHicOjpxKciB_X5uEWdzNuWfgTsjIthYJeWTwwoXIXsuCxxEHJqN8cUPGTAoZCZ79jsgYgPGIZTK7IxPv9wCQ9jcmpyv-Rjc7pMuddtoEdLUPtaFzE-pTHc60regPbrtGh9ad6YIusWk8LTtX2y0NfXFtTOccWoNU25K-4wmb9nhAG4buyvquqW3v8L1Y99Q9ua104_HhmlOy-fzYLL-jfP21Ws7zyKRJEpWAcZVVSSIkS6uiZGiMTsuCGQAuEi4LLbhkMaIUFfCsELPEzIo4K9MiZjwTU_J00R5d-9ehD2rfds72H5VgAAJgxpKeer5QxrXeO6zU0dUH7c6KgRqGVcOwalhK5QvxDzHGbME |
ContentType | Journal Article |
Copyright | Copyright American Diabetes Association Jun 2024 |
Copyright_xml | – notice: Copyright American Diabetes Association Jun 2024 |
DBID | AAYXX CITATION K9. NAPCQ |
DOI | 10.2337/db24-2019-LB |
DatabaseName | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitle | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitleList | CrossRef ProQuest Health & Medical Complete (Alumni) |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
ExternalDocumentID | 10_2337_db24_2019_LB |
Genre | Conference Proceeding |
GroupedDBID | --- .55 .XZ 08P 0R~ 18M 29F 2WC 354 4.4 53G 5GY 5RE 5RS 5VS 6PF 8R4 8R5 AAFWJ AAQQT AAWTL AAYEP AAYXX ABOCM ACGFO ACGOD ACPRK ADBBV AEGXH AENEX AERZD AHMBA AIAGR AIZAD ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BES BTFSW CITATION CS3 DIK DU5 E3Z EBS EDB EMOBN EX3 F5P FRP GX1 H13 HZ~ IAO IEA IHR INH INR IOF IPO K2M KQ8 L7B M5~ O5R O5S O9- OHH OK1 OVD P2P PCD Q2X RHI RPM SJN SV3 TDI TEORI TR2 VVN W8F WH7 WOQ WOW X7M YFH YHG YOC ZY1 ~KM K9. NAPCQ |
ID | FETCH-LOGICAL-c655-d0e4f7f553916fbd1ecca6db1c0023529ba32914ee93f027b385c8b47d6b41273 |
ISSN | 0012-1797 |
IngestDate | Mon Jun 30 10:45:26 EDT 2025 Tue Jul 01 04:15:22 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c655-d0e4f7f553916fbd1ecca6db1c0023529ba32914ee93f027b385c8b47d6b41273 |
Notes | ObjectType-Conference Proceeding-1 SourceType-Scholarly Journals-1 content type line 14 |
PQID | 3100300815 |
PQPubID | 34443 |
ParticipantIDs | proquest_journals_3100300815 crossref_primary_10_2337_db24_2019_LB |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-06-14 |
PublicationDateYYYYMMDD | 2024-06-14 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-14 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationYear | 2024 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
SSID | ssj0006060 |
Score | 2.451899 |
Snippet | Introduction & Objective: To investigate the aberrant distribution and clinical relevance of regulatory B cells (Bregs) subsets in the peripheral blood of... |
SourceID | proquest crossref |
SourceType | Aggregation Database Index Database |
StartPage | 1 |
SubjectTerms | Beta cells Blood levels CD19 antigen CD27 antigen CD38 antigen Correlation analysis Diabetes Diabetes mellitus (non-insulin dependent) Flow cytometry Insulin resistance Interleukin 10 Interleukin 17 Interleukin 6 Peripheral blood Plasma levels Tumor necrosis factor-α γ-Interferon |
Title | 2019-LB: The Characteristic Activity of Regulatory B Cells during the Occurrence and Development of Insulin Resistance |
URI | https://www.proquest.com/docview/3100300815 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELYKSIgL4rXiLR_ghLLbOHaacEvLo0VtkVZdLbeodpwTKogWDvx6ZvxoUtQDcImqKHYjzxfPw_PNEHI2jsaqFKrE8JIKOCiEIEk4C8C9jSRXTLAUycmDYdz9x-8exEOj8Vpnl8zkb_W-lFfyE6nCPZArsmS_Idn5pHADfoN84QoShuuXZAxqNQ36bZ850VkovnyRKdcZwtQbMS3n8UC9fdHRj49TT1BEwxNLDb_YcrM2M3meSGSZJjZd_a-eorHpUeIs2qta8PZzW59amOH_dc-EAHrD274vYoXx6m5mSVP93l1vTooYZEYzZMPaY_dmd7x3Q12cgnHMp7L8UL_3hgyLobbqe69tY-IwZvqYmqBoHi7b3Vlk6gMUEiZ3C1xpMX9y_0m5zVMOwdnB8TmOznF03m-vkDUG3gXzQR6nwMGns8wl98KWL4Gj_9T_e9GSWVTkxjoZbZFN51bQzGJkmzT0ZIesD1zixC55c7NdUgAKXQQK9UChTyWtgELb1ACFWqBQAAqtgEIBKLQGFBzrgEIroOyR0c31qNMNXMuNQMVCBEVT87JVCoF07FIWIX7gcSFDZeoisVSOI5aGXOs0KpusJaNEqETyVhFLHoIl_IusTp4mep_QBCZKOTwSC2QgSRknrNBcFoo10Sk_IOd-9fJnW1glXyajA3LslzZ3n940x1OpCK1ZcfjFaY7IRgXKY7I6e3nVJ2BOzuSpEf4HFA1vsA |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2019-LB%3A+The+Characteristic+Activity+of+Regulatory+B+Cells+during+the+Occurrence+and+Development+of+Insulin+Resistance&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=WEI%2C+LINGLING&rft.au=ZHANG%2C+LIJIE&rft.au=MA%2C+YAN&rft.au=ZHAO%2C+DONG&rft.date=2024-06-14&rft.issn=0012-1797&rft.volume=73&rft.issue=Supplement_1&rft_id=info:doi/10.2337%2Fdb24-2019-LB&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_db24_2019_LB |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |